Monogram Technologies Announces the Mandatory Conversion of 8.00% Series D Convertible Cumulative Preferred Stock
Monogram Technologies to Host First Quarter 2025 Results Conference Call on Wednesday, May 14, 2025 at 4:30 p.m. Eastern Time
CORRECTION FROM SOURCE: Monogram Technologies Receives Regulatory Approval to Start Clinical Trials in India
Monogram Technologies Granted Regulatory Approval to Import mBôs TKA System for Clinical Investigation in India
Monogram Technologies Partners with Urvin to Launch an Exclusive, Verified Shareholder Community
Monogram Technologies Announces FDA 510(k) Clearance for the Monogram mBôsTM TKA System
CORRECTION: Monogram Technologies Reports Full Year 2024 Financial Results
Monogram Technologies Reports Full Year 2024 Financial Results
Monogram Technologies to Participate in the 37th Annual ROTH Conference in California March 16-18, 2025
Monogram Technologies to Host Fourth Quarter and Full Year 2024 Results Conference Call on Wednesday, March 12, 2025 at 4:30 p.m. Eastern Time
Monogram Technologies Provides Regulatory Update on mBôs TKA System and Clinical Trial Preparation in India